Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials
View ORCID ProfileAlexander D. Sherry, Pavlos Msaouel, Gabrielle S. Kupferman, Timothy A. Lin, Joseph Abi Jaoude, Ramez Kouzy, Molly B. El-Alam, Roshal Patel, Alex Koong, Christine Lin, Adina H. Passy, Avital M. Miller, Esther J. Beck, View ORCID ProfileC. David Fuller, Tomer Meirson, View ORCID ProfileZachary R. McCaw, Ethan B. Ludmir
doi: https://doi.org/10.1101/2024.07.23.24310891
Alexander D. Sherry
1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MDPavlos Msaouel
2Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
3Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MD, PhDGabrielle S. Kupferman
1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
BATimothy A. Lin
4Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
MD, MBAJoseph Abi Jaoude
5Department of Radiation Oncology, Stanford University, Stanford, CA, USA
MDRamez Kouzy
1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MDMolly B. El-Alam
1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MPHRoshal Patel
6Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
MDAlex Koong
1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Christine Lin
1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
BAAdina H. Passy
1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MPHAvital M. Miller
1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
BAEsther J. Beck
1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
BAC. David Fuller
1Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MD, PhDTomer Meirson
7Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel
MD PhDZachary R. McCaw
8Insitro, South San Francisco, CA, USA
9Department of Biomedical Informatics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
PhDEthan B. Ludmir
10Department of Gastrointestinal Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
11Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MDArticle usage
Posted July 24, 2024.
Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials
Alexander D. Sherry, Pavlos Msaouel, Gabrielle S. Kupferman, Timothy A. Lin, Joseph Abi Jaoude, Ramez Kouzy, Molly B. El-Alam, Roshal Patel, Alex Koong, Christine Lin, Adina H. Passy, Avital M. Miller, Esther J. Beck, C. David Fuller, Tomer Meirson, Zachary R. McCaw, Ethan B. Ludmir
medRxiv 2024.07.23.24310891; doi: https://doi.org/10.1101/2024.07.23.24310891
Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials
Alexander D. Sherry, Pavlos Msaouel, Gabrielle S. Kupferman, Timothy A. Lin, Joseph Abi Jaoude, Ramez Kouzy, Molly B. El-Alam, Roshal Patel, Alex Koong, Christine Lin, Adina H. Passy, Avital M. Miller, Esther J. Beck, C. David Fuller, Tomer Meirson, Zachary R. McCaw, Ethan B. Ludmir
medRxiv 2024.07.23.24310891; doi: https://doi.org/10.1101/2024.07.23.24310891
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (206)
- Cardiovascular Medicine (2968)
- Dermatology (252)
- Emergency Medicine (445)
- Epidemiology (12803)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4617)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2941)
- Health Policy (1072)
- Hematology (393)
- HIV/AIDS (932)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (475)
- Neurology (4403)
- Nursing (238)
- Nutrition (648)
- Oncology (2292)
- Ophthalmology (651)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (280)
- Palliative Medicine (84)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (502)
- Public and Global Health (6996)
- Radiology and Imaging (1542)
- Respiratory Medicine (920)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)